Cited by 77Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease PreventionBlood Pressure and Hypertension Studies

Nitric oxide deficiency is a primary driver of hypertension

Bryan, Nathan S.·2022·Biochemical Pharmacology

Abstract

Hypertension remains a global health crisis. High blood pressure is the number one modifiable risk factor in the onset and progression of cardiovascular disease. Despite many different classes of drug therapies approved for hypertension, the use of polypharmacy and recommendations on lifestyle modification, many patients still suffer from uncontrolled or unmanaged hypertension. Nitric oxide is a naturally produced vasodilator that controls and regulates vascular tone and therefore controls and regulates blood pressure. Research over the past 40 years reveals that loss of nitric oxide production, termed endothelial dysfunction, is the earliest event in the development of hypertension. Strategies aimed at preventing the loss of nitric oxide production and/or therapeutic strategies designed to restore nitric oxide production will likely have a positive effect on patients' health and lead to better management of blood pressure. This review article will focus on the loss of nitric oxide production as the primary contributor to hypertension and also discuss safe and clinically proven strategies to restore nitric oxide production and recapitulate nitric oxide based signaling in humans.

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2022.115325

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nitric oxide produced by eNOS induces vasodilation, and its deficiency under high angiotensin II levels leads to increased constriction of blood vessels.

    “Another crucial mechanism involves nitric oxide (NO) production by endothelial nitric oxide synthase (eNOS); NO induces vasodilation, and its deficiency under high angiotensin II levels leads to increased constriction of blood vessels [48].”

Cites

Flagged first, then by citations

3 of the 115 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Bryan, N. S.
Corresponding author
Bryan, Nathan S.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2022-12
Volume
206
Pages
115325
ISSN
0006-2952 (ISSN-L)
OpenAlex
W4308453693
Cited by
77
References
115
Citations by year
2026: 23 · 2025: 27 · 2024: 21 · 2023: 6
FWCI
1.86
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
hypertension, nitric oxide, endothelial dysfunction, nitric oxide deficiency, nitric oxide signaling, vasodilation, vascular tone, cardiovascular disease, blood pressure regulation
MeSH terms
Blood Pressure, Cardiovascular Diseases, Endothelium, Vascular, Humans, Hypertension, Nitric Oxide, Vasodilator Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review